Talis Biomedical (NASDAQ:TLIS) Shares Up 0.8% – Here’s What Happened

Talis Biomedical Co. (NASDAQ:TLIS)’s share price rose 0.8% during mid-day trading on Friday . The stock traded as high as $1.71 and last traded at $1.71. Approximately 402 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 12,678 shares. The stock had previously closed at $1.70.

Talis Biomedical Price Performance

The stock has a market capitalization of $3.12 million, a price-to-earnings ratio of -0.06 and a beta of 1.58. The stock has a 50-day moving average of $1.75 and a 200 day moving average of $4.02.

Hedge Funds Weigh In On Talis Biomedical

An institutional investor recently raised its position in Talis Biomedical stock. BML Capital Management LLC grew its position in Talis Biomedical Co. (NASDAQ:TLIS) by 481.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 248,702 shares of the company’s stock after purchasing an additional 205,959 shares during the period. Talis Biomedical comprises about 0.3% of BML Capital Management LLC’s portfolio, making the stock its 24th largest position. BML Capital Management LLC owned approximately 13.66% of Talis Biomedical worth $460,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 43.77% of the company’s stock.

About Talis Biomedical

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.